Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62.9M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
56.6M
-
Shares change
-
-925K
-
Total reported value, excl. options
-
$380M
-
Value change
-
+$1.09M
-
Put/Call ratio
-
6.61
-
Number of buys
-
66
-
Number of sells
-
-71
-
Price
-
$6.71
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q4 2022
158 filings reported holding MGNX - MACROGENICS INC - COM as of Q4 2022.
MACROGENICS INC - COM (MGNX) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.6M shares
of 62.9M outstanding shares and own 89.98% of the company stock.
Largest 10 shareholders include Bellevue Group AG (8.98M shares), ARMISTICE CAPITAL, LLC (6.09M shares), BlackRock Inc. (5.99M shares), VANGUARD GROUP INC (4.44M shares), T. Rowe Price Investment Management, Inc. (2.88M shares), MILLENNIUM MANAGEMENT LLC (2.81M shares), WASATCH ADVISORS INC (2.24M shares), Assenagon Asset Management S.A. (1.49M shares), STATE STREET CORP (1.29M shares), and TWO SIGMA ADVISERS, LP (1.14M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.